Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-20T22:07:40.911Z Has data issue: false hasContentIssue false

Chapter 13 - Movement disorders in hematological disease

from Section II - Movement disorders in systemic disease

Published online by Cambridge University Press:  05 April 2014

By
Sheila R. Eichenseer  and
Deborah A. Hall
Edited by
Werner Poewe  and
Joseph Jankovic
Sheila R. Eichenseer
Affiliation:
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
Deborah A. Hall
Affiliation:
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
Werner Poewe
Affiliation:
Medical University Innsbruck
Joseph Jankovic
Affiliation:
Baylor College of Medicine, Texas
Get access

Summary

Introduction

Unlike other systemic diseases, movement disorders are infrequent in hematological disease. Although some hematological diseases, such as superficial siderosis and neuroacanthocytosis, may present initially with neurological symptoms, the majority of patients with these diseases are identified due to complications related to the underlying hematological abnormalities. Each hematological disorder will be described, with clinical manifestations, pathophysiology, and treatment, with genetic considerations if appropriate.

Hemochromatosis

Hemochromatosis is characterized by enhanced intestinal absorption of dietary iron. The presence of an association between hemochromatosis and movement disorders is controversial (Russo et al. 2004). Hereditary hemochromatosis (HH), which results in iron accumulation, is a common genetic disorder, affecting 0.5 percent of the US population. It is estimated that one in ten individuals are carriers of the most frequent mutation and they are typically Caucasians of Northern European descent (Feder et al. 1996). Movement disorders in individuals with HH have only infrequently been reported in the literature. This section will summarize the cases of movement disorders in the setting of hemochromatosis described in the literature. However, it remains unclear whether these rare cases can be attributed to hemochromatosis or are coincidental.

Type
Chapter
Information
Movement Disorders in Neurologic and Systemic Disease , pp. 189 - 202
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aisen, P., Enns, C., and Wessling-Resnick, M. (2001). “Chemistry and biology of eukaryotic iron metabolism,” Int. J. Biochem. Cell Biol. 33: 940–59.CrossRefGoogle ScholarPubMed
Ali, S. K., Wilimas, J., and Goff, J. (1978). “Choreiform activity in hemoglobin SC disease,” J. Pediatr. 93: 1062.CrossRefGoogle ScholarPubMed
Alonso, M. E., Teixeira, F., Jimenez, G., and Escobar, A. (1989). “Chorea-acanthocytosis: report of a family and neuropathological study of two cases,” Can. J. Neurol. Sci. 16: 426–31.CrossRefGoogle ScholarPubMed
Babitt, J. L. and Lin, H. Y. (2011). “The molecular pathogenesis of hereditary hemochromatosis,” Semin. Liver Dis. 31: 280–92.CrossRefGoogle ScholarPubMed
Bassen, F. A. and Kornzweig, A. L. (1950). “Malformation of the erythrocytes in a case of atypical retinitis pigmentosa,” Blood 5: 381–7.Google Scholar
Batchelor, T. T., Platten, M., Palmer-Toy, D. E., Hunter, G. J., Lev, M. H., Dalmau, J., et al. (1998). “Chorea as a paraneoplastic complication of Hodgkin’s disease,” Journal of Neuro-oncology 36: 185–90.CrossRefGoogle ScholarPubMed
Bayreuther, C., Borg, M., Ferrero-Vacher, C., Chaussenot, A., and Lebrun, C. (2010). “Chorea-acanthocytosis without acanthocytes,” Revue Neurologique 166: 100–3.CrossRefGoogle ScholarPubMed
Benz, R., Viecelli, A., Taverna, C., and Schelosky, L. (2012). “Paroxysmal non-kinesigenic dyskinesia due to spinal cord infiltration of low-grade B cell non-Hodgkin’s lymphoma,” Annals of Hematology 91: 463–5.CrossRefGoogle ScholarPubMed
Berg, D. and Hochstrasser, H. (2006). “Iron metabolism in Parkinsonian syndromes,” Mov. Disord. 21: 1299–310.CrossRefGoogle ScholarPubMed
Bota, D. A. and Dafer, R. M. (2009). “Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report,” Southern Medical Journal 102: 1071–4.CrossRefGoogle ScholarPubMed
Brooks, D. J., Ibanez, V., Playford, E. D., Sawle, G. V., Leigh, P. N., Kocen, R. S., et al. (1991). “Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study. Annals of Neurology 30: 166–71.CrossRefGoogle ScholarPubMed
Cao, M., Olsen, R. J., and Zu, Y. (2006). “Polycythemia vera: new clinicopathologic perspectives,” Arch. Pathol. Lab. Med. 130: 1126–32.Google ScholarPubMed
Chowers, I., Banin, E., Merin, S., Cooper, M., and Granot, E. (2001). “Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients,” Eye (London, England) 15: 525–30.CrossRefGoogle Scholar
Collins, J. C., Scheinberg, I. H., Giblin, D. R., and Sternlieb, I. (1989). “Hepatic peroxisomal abnormalities in abetalipoproteinemia,” Gastroenterology 97: 766–70.CrossRefGoogle ScholarPubMed
Costello, D. J., Walsh, S. L., Harrington, H. J., and Walsh, C. H. (2004). “Concurrent hereditary haemochromatosis and idiopathic Parkinson’s disease: a case report series,” J. Neurol. Neurosurg. Psychiatry 75(4): 631–3.CrossRefGoogle ScholarPubMed
Dekker, M. C., Giesbergen, P. C., Njajou, O. T., van Swieten, J. C., Hofman, A., Breteler, M. M., et al. (2003). “Mutations in the hemochromatosis gene (HFE), Parkinson’s disease and parkinsonism,” Neurosci. Lett. 348: 117–19.CrossRefGoogle Scholar
Demarquay, G., Setiey, A., Morel, Y., Trepo, C., Chazot, G., and Broussolle, E. (2000). “Clinical report of three patients with hereditary hemochromatosis and movement disorders,” Mov. Disord. 15(6): 1204–9.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Di Filippo, M., Floridi, P., Rossi, V., Mattucci, E., Rossi, A., Calabresi, P., et al. (2010). “A young patient with type C multiple system atrophy and hereditary hemochromatosis,” J. Neurol. 257(2): 294–5.CrossRefGoogle Scholar
Dydak, U., Mueller, S., Sandor, P. S., Meier, D., Boesiger, P., and Jung, H. H. (2006). “Cerebral metabolic alterations in McLeod syndrome,” European Neurology 56: 17–23.CrossRefGoogle ScholarPubMed
Edwards, T. C., Zrinzo, L., Limousin, P., and Foltynie, T. (2011). “Deep brain stimulation in the treatment of chorea,” Movement Disorders: Official Journal of the Movement Disorder Society 27(3): 357–63.CrossRefGoogle ScholarPubMed
Fahn, S. (1995). “Sydenham and other forms of chorea,” in Rowland, L. P. (ed.), Merritt’s Textbook of Neurology (Philadelphia, PA: Williams & Wilkins), pp. 699–703.Google Scholar
Fearnley, J. M., Stevens, J. M., and Rudge, P. (1995). “Superficial siderosis of the central nervous system,” Brain 118(Pt. 4): 1051–66.CrossRefGoogle ScholarPubMed
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., et al. (1996). “A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis,” Nat. Genet. 13: 399–408.CrossRefGoogle ScholarPubMed
Gherardi, R., Roualdes, B., Fleury, J., Prost, C., Poirier, J., and Degos, J. D. (1985). “Parkinsonian syndrome and central nervous system lymphoma involving the substantia nigra, a case report,” Acta Neuropathologica 65: 338–43.CrossRefGoogle ScholarPubMed
Hardie, R. J., Pullon, H. W., Harding, A. E., Owen, J. S., Pires, M., Daniels, G. L., et al. (1991). “Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases,” Brain 114(Pt. 1A): 13–49.Google ScholarPubMed
Haussermann, P., Wilhelm, T., Keinath, S., Stolzle, C., Conrad, B., and Ceballos-Baumann, A. (2001). “Primary central nervous system lymphoma in the SMA presenting as rapidly progressive parkinsonism,” Movement Disorders: Official Journal of the Movement Disorder Society 16: 962–5.CrossRefGoogle ScholarPubMed
Heckmann, J. G., Lang, C. J., and Neundorfer, B. (1999). “Comment on the paper: Batchelor TT, Platten M, Palmer-Toy DE, Hunter GJ, Lev MH, Dalmau J, Hochberg FH: Chorea as a paraneoplastic complication of Hodgkin’s disease,” Journal of Neuro-Oncology 41: 95–6.CrossRefGoogle Scholar
Henkel, K., Danek, A., Grafman, J., Butman, J., and Kassubek, J. (2006). “Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study,” Mov. Dis. 21: 1728–31.CrossRefGoogle ScholarPubMed
Hentati, F., El-Euch, G., Bouhlal, Y., and Amouri, R. (2012). “Ataxia with vitamin E deficiency and abetalipoproteinemia” in Vinken, P. J. and Bruyn, G. W. (eds.), Handbook of Clinical Neurology (Amsterdam: Elsevier), vol. 103, pp. 295–305.Google Scholar
Huang, H. C., Wu, Y. C., Shih, L. Y., Lo, W. C., Tsai, C. H., and Shyu, W. C. (2011). “Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea,” J. Neurol. 258: 2054–7.CrossRefGoogle ScholarPubMed
Ishihara, S., Kano, O., Ikeda, K., Shimokawa, R., Kawabe, K., and Iwasaki, Y. (2011). “Clinicoradiological changes of brain NK/T cell lymphoma manifesting pure akinesia: a case report,” BMC Neurology 11: 137.CrossRefGoogle ScholarPubMed
Jones, H. R. and Hedley-Whyte, E. T. (1983). “Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs,” Neurology 33(11): 1479–83.CrossRefGoogle ScholarPubMed
Jung, H. H., Danek, A., and Frey, B. M. (2007). “McLeod syndrome: a neurohaematological disorder,” Vox Sanguinis 93: 112–21.CrossRefGoogle ScholarPubMed
Jung, H. H., Danek, A., and Walker, R. H. (2011). “Neuroacanthocytosis syndromes,” Orphanet Journal of Rare Diseases 6: 68.CrossRefGoogle ScholarPubMed
Jung, H. H., Hergersberg, M., Kneifel, S., Alkadhi, H., Schiess, R., Weigell-Weber, M., et al. (2001). “McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings,” Annals of Neurology 49: 384–92.CrossRefGoogle ScholarPubMed
Kageyama, Y., Matsumoto, K., Ichikawa, K., Ueno, S., Ichiba, M., Nakamura, M., et al. (2007). “A new phenotype of chorea-acanthocytosis with dilated cardiomyopathy and myopathy,” Mov. Dis. 22: 1669–70.CrossRefGoogle ScholarPubMed
Kim, W., Kim, J. S., Lee, K. S., Kim, Y. I., Park, C. W., and Chung, Y. A. (2008). “No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI,” Neurol. Sci. 29: 351–4.CrossRefGoogle Scholar
Koenig, M. (2003). “Rare forms of autosomal recessive neurodegenerative ataxia,” Seminars in Pediatric Neurology 10: 183–92.CrossRefGoogle ScholarPubMed
Koeppen, A. H., Michael, S. C., Li, D., Chen, Z., Cusack, M. J., Gibson, W. M., et al. (2008). “The pathology of superficial siderosis of the central nervous system,” Acta Neuropathol. 116: 371–82.CrossRefGoogle ScholarPubMed
Kudo, A., Tanaka, N., Oogaki, S., Niimura, T., and Kanehisa, T. (1977). “Hypobetalipoproteinemia with abnormal prebetalipoprotein,” Journal of the Neurological Sciences 31: 411–19.CrossRefGoogle ScholarPubMed
Kumar, H., Masiowski, P., and Jog, M. (2009). “Chorea in the elderly with mutation positive polycythemia vera: a case report,” Can. J. Neurol. Sci. 36: 370–2.CrossRefGoogle ScholarPubMed
Kumar, N., Cohen-Gadol, A. A., Wright, R. A., Miller, G. M., Piepgras, D. G., and Ahlskog, J. E. (2006). “Superficial siderosis,” Neurology 66: 1144–52.CrossRefGoogle ScholarPubMed
Kumar, N., Fogelson, J. L., Morris, J. M., and Pichelmann, M. A. (2012). “Superficial siderosis should be included in the differential diagnosis of motor neuron disease,” Neurologist 18: 139–45.CrossRefGoogle ScholarPubMed
Kumar, N., Miller, G. M., Piepgras, D. G., and Mokri, B. (2010). “A unifying hypothesis for a patient with superficial siderosis, low-pressure headache, intraspinal cyst, back pain, and prominent vascularity,” J. Neurosurg. 113: 97–101.CrossRefGoogle ScholarPubMed
Levy, M. and Llinas, R. (2012). “Pilot safety trial of deferiprone in 10 subjects with superficial siderosis,” Stroke 43: 120–4.CrossRefGoogle ScholarPubMed
Lima, M. A., Maradei, S., and Maranhao Filho, P. (2009). “Cyclosporine-induced parkinsonism,” Journal of Neurology 256: 674–5.CrossRefGoogle ScholarPubMed
Lin, C. M. and Hong, K. (2010). “Cerebral infratentorial large B-cell lymphoma presenting as Parkinsonism,” Tohoku Journal of Experimental Medicine 220: 187–90.CrossRefGoogle ScholarPubMed
Lok, C. Y., Merryweather-Clarke, A. T., Viprakasit, V., Chinthammitr, Y., Srichairatanakool, S., Limwongse, C., et al. (2009). “Iron overload in the Asian community,” Blood 114: 20–5.CrossRefGoogle ScholarPubMed
Midi, I., Dib, H., Koseoglu, M., Afsar, N., and Gunal, D. I. (2006). “Hemichorea associated with polycythaemia vera,” Neurol. Sci. 27: 439–41.CrossRefGoogle ScholarPubMed
Milia, A., Pilia, G., Mascia, M. G., and Manconi, F. M. (2010). “Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism,” Journal of Neuro-oncology 100: 281–3.CrossRefGoogle ScholarPubMed
Moulignier, A., Allo, S., Zittoun, R., and Gout, O. (2002). “Recombinant interferon-alpha-induced chorea and frontal subcortical dementia,” Neurology 58: 328–30.CrossRefGoogle ScholarPubMed
Narcisi, T. M., Shoulders, C. C., Chester, S. A., Read, J., Brett, D. J., Harrison, G. B., et al. (1995). “Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia,” American Journal of Human Genetics 57: 1298–310.Google ScholarPubMed
Nazabal, E. R., Lopez, J. M., Perez, P. A., and Del Corral, P. R. (2000). “Chorea disclosing deterioration of polycythaemia vera,” Postgrad. Med. J. 76: 658–9.CrossRefGoogle ScholarPubMed
Necioglu Orken, D., Yldrmak, Y., Kenangil, G., Kandraloglu, N., Forta, H., and Celik, M. (2009). “Intrathecal methotrexate-induced acute chorea,” Journal of Pediatric Hematology/Oncology 31: 57–8.CrossRefGoogle ScholarPubMed
Nielsen, J. E., Jensen, L. N., and Krabbe, K. (1995). “Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome,” J. Neurol. Neurosurg. Psychiatry 59(3): 318–21.CrossRefGoogle ScholarPubMed
Nuti, A., Ceravolo, R., Salvetti, S., Gambaccini, G., Bonuccelli, U., and Capochiani, E. (2000). “Paraneoplastic choreic syndrome during non-Hodgkin’s lymphoma,” Mov. Dis. 15: 350–2.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Oechsner, M., Buchert, R., Beyer, W., and Danek, A. (2001). “Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis,” Journal of Neurology, Neurosurgery, and Psychiatry 70: 517–20.CrossRefGoogle ScholarPubMed
Offenbacher, H., Fazekas, F., Schmidt, R., Kapeller, P., and Fazekas, G. (1996). “Superficial siderosis of the central nervous system: MRI findings and clinical significance,” Neuroradiology 38(Suppl. 1): S51–6.CrossRefGoogle ScholarPubMed
Phatak, P., Brissot, P., Wurster, M., Adams, P. C., Bonkovsky, H. L., Gross, J., et al. (2010). “A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis,” Hepatology 52: 1671–779.CrossRefGoogle ScholarPubMed
Poewe, W. H., Kleedorfer, B., Willeit, J., Gerstenbrand, F. (1988). “Primary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystonia,” Mov. Dis. 3: 320–5.CrossRefGoogle ScholarPubMed
Posti, J. P., Juvela, S., Parkkola, R., and Roine, S. (2011). “Three cases of superficial siderosis of the central nervous system and review of the literature,” Acta Neurochir (Wien) 153: 2067–73.CrossRefGoogle ScholarPubMed
Pramstaller, P. P., Salerno, A., Bhatia, K. P., Prugger, M., and Marsden, C. D. (1999). “Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia,” Journal of Neurology 246: 934–8.CrossRefGoogle ScholarPubMed
Pratesi, A., Vella, A., Pasini, E., Salvi, F., and Mascalchi, M. (2008). “Parkinsonism in polycythaemia vera probably due to manganism,” Mov. Disord. 23: 2420–1.CrossRefGoogle ScholarPubMed
Rampoldi, L., Danek, A., and Monaco, A. P. (2002). “Clinical features and molecular bases of neuroacanthocytosis,” Journal of Molecular Medicine (Berlin, Germany) 80: 475–91.CrossRefGoogle ScholarPubMed
Ramu, C. S., Raju, G. B., Rao, K. S., and Venkateswarlu, K. (2008). “Uncommon neurological manifestations of hemolytic anemia: a report of two cases,” Neurology India 56: 201–3.Google ScholarPubMed
Rauch, R., Jungert, J., Rupprecht, T., and Greil, J. (2001). “Torticollis revealing as a symptom of acute lymphoblastic leukaemia in a fourteen-month-old girl,” Acta Paediatrica (Oslo, Norway) 90: 587–8.CrossRefGoogle Scholar
Rogers, V. E., Marcus, C. L., Jawad, A. F., Smith-Whitley, K., Ohene-Frempong, K., Bowdre, C., et al. (2011). “Periodic limb movements and disrupted sleep in children with sickle cell disease,” Sleep 34: 899–908.Google ScholarPubMed
Rollnik, J. D., Winkler, T., and Ganser, A. (2003). “A case of symptomatic paroxysmal kinesigenic dsykinesia with primary central nervous system lymphoma,” Der Nervenarzt 74: 362–5.CrossRefGoogle ScholarPubMed
Russo, N., Edwards, M., Andrews, T., O’Brien, M., and Bhatia, K. P. (2004). “Hereditary haemochromatosis is unlikely to cause movement disorders – a critical review,” J. Neurol. 251: 849–52.CrossRefGoogle ScholarPubMed
Rutgers, M. P., Pielen, A., and Gille, M. (2007). “Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association?” J. Neurol. 254(9): 1296–7.CrossRefGoogle ScholarPubMed
Saiki, S., Hirose, G., Sakai, K., Matsunari, I., Higashi, K., Saiki, M., et al. (2004). “Chorea-acanthocytosis associated with Tourettism,” Mov. Dis. 19: 833–6.CrossRefGoogle ScholarPubMed
Saiki, S., Sakai, K., Jankovic, J., and Tolosa, E. (2007). Neuroacanthocytosis. Parkinson’s Disease and Movement Disorders, 5th edn. (Philadelphia, PA: Lippincott Williams & Wilkins), pp. 567–73.Google Scholar
Samii, A., Dahlen, D. D., Spence, A. M., Maronian, N. C., Kraus, E. E., and Lennon, V. A. (2003). “Paraneoplastic movement disorder in a patient with non-Hodgkin’s lymphoma and CRMP-5 autoantibody,” Mov. Dis. 18: 1556–8.CrossRefGoogle Scholar
Sanchez-Guerra, M., Cerezal, L., Leno, C., Diez, C., Figols, J., and Berciano, J. (2001). “Primary brain lymphoma presenting as Parkinson’s disease,” Neuroradiology 43: 36–40.CrossRefGoogle ScholarPubMed
Santos, P. C., Krieger, J. E., and Pereira, A. C. (2012). “Molecular diagnostic and pathogenesis of hereditary hemochromatosis,” Int. J. Mol. Sci. 13: 1497–511.CrossRefGoogle ScholarPubMed
Schiffer, D. (1997). Brain Tumours (New York: Springer).CrossRefGoogle Scholar
Schroder, J. and Haan, J. (1987). “Extrapyramidal syndrome in idiopathic hemochromatosis. Significance of laboratory chemical, neurophysiologic and imaging procedures (CCT, MRT),” Nervenarzt 58(9): 577–8.Google Scholar
Segal, S. and Sharma, S. (2005). “Ophthaproblem. Vitamin A and vitamin E,” Can. Fam. Phys. 51: 1079, 1085–6.Google ScholarPubMed
Selcuk, N. A. and Fenercioglu, A. (2010). “Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case,” Clinical Nuclear Medicine 35: 557–8.CrossRefGoogle ScholarPubMed
Severs, M., Boelens, H. M., Diraoui, S. B., and Schuur, J. (2012). “Chorea and a frontal lobe syndrome: a rare neurological presentation of polycythemia vera; a case report,” J. Am. Geriatr. Soc. 60: 589–90.CrossRefGoogle Scholar
Sheen, V. L., Asimakopoulos, F., Heyman, E., Henderson, G., and Feske, S. K. (2002). “Hemichorea as a presentation of recurrent non-Hodgkin’s lymphoma,” Journal of Neurology 249: 1746–8.CrossRefGoogle ScholarPubMed
Sobrevilla, L. A., Goodman, M. L., and Kane, C. A. (1964). “Demyelinating central nervous system disease, macular atrophy and acanthocytosis (Bassen-Kornzweig syndrome),” Am. J. Med. 37: 821–8.CrossRefGoogle Scholar
Staerk, J., Kallin, A., Demoulin, J. B., Vainchenker, W., and Constantinescu, S. N. (2005). “JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor,” J. Biol. Chem. 280: 41893–9.CrossRefGoogle ScholarPubMed
Suzuki, T., Yamamoto, M., Saitoh, M., Aoki, A., Imai, H., and Narabayashi, H. (1984). “A case of intracranial malignant lymphoma with pure akinesia and repeated regression on CT scans,” No to shinkei (Brain and Nerve) 36: 689–96.Google ScholarPubMed
Swinkels, D. W., Janssen, M. C., Bergmans, J., and Marx, J. J. (2006). “Hereditary hemochromatosis: genetic complexity and new diagnostic approaches,” Clin. Chem. 52: 950–68.CrossRefGoogle ScholarPubMed
Tan, E. K., Chan, L. L., Auchus, A. P., and Wong, M. C. (2003). “Reversible choreoathetosis in primary cerebral lymphoma: clinicoradiologic correlation,” European Neurology 50: 53–4.CrossRefGoogle ScholarPubMed
Thomas, M. and Jankovic, J. (2006). Neuroacanthocytosis. Neurologic Therapeutics: Principles and Practice (Abingdon, Oxon, UK: Informa Healthcare), pp. 2882–9.Google Scholar
Tyler, G. K., Martin, T. P., and Baguley, D. M. (2012). “Systematic review of outcome of cochlear implantation in superficial siderosis,” Otol. Neurotol. 33(6): 976–82.Google ScholarPubMed
van den Buuse, M. and Webber, K. M. (2000). “Endothelin and dopamine release,” Prog. Neurobiol. 60: 385–405.CrossRefGoogle ScholarPubMed
van Harskamp, N. J., Rudge, P., and Cipolotti, L. (2005). “Cognitive and social impairments in patients with superficial siderosis,” Brain 128: 1082–92.CrossRefGoogle ScholarPubMed
Vetrugno, R., Provini, F., and Montagna, P. (2006). “Restless legs syndrome and periodic limb movements,” Reviews in Neurological Diseases 3: 61–70.Google ScholarPubMed
Vigliani, M. C., Honnorat, J., Antoine, J. C., Vitaliani, R., Giometto, B., Psimaras, D., et al. (2011). “Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience,” Journal of Neurology 258: 2058–68.CrossRefGoogle ScholarPubMed
Walker, R. H., Danek, A., Dobson-Stone, C., Guerrini, R., Jung, H. H., Lafontaine, A. L., et al. (2006). “Developments in neuroacanthocytosis: expanding the spectrum of choreatic syndromes,” Mov. Dis. 21: 1794–805.CrossRefGoogle ScholarPubMed
Walker, R. H., Jung, H. H., and Danek, A. (2011). “Neuroacanthocytosis” in P. J. Vinken and G. W. Bruyn (eds.), Handbook of Clinical Neurology 100: 141–51.CrossRefGoogle ScholarPubMed
Walterfang, M., Evans, A., Looi, J. C., Jung, H. H., Danek, A., Walker, R. H., et al. (2011). “The neuropsychiatry of neuroacanthocytosis syndromes,” Neuroscience and Biobehavioral Reviews 35: 1275–83.CrossRefGoogle ScholarPubMed
Wang, K., Xu, Z., Xiong, G., and Benyan, L. (2010). “Superficial siderosis of the central nervous system manifested with seizures,” J. Clin. Neurosci. 17: 277–8.CrossRefGoogle ScholarPubMed
Williams-Gray, C. H., Aliyu, S. H., Lever, A. M., Dean, A. F., and Lennox, G. G. (2007). “Reversible parkinsonism in a patient with progressive multifocal leucoencephalopathy,” Journal of Neurology, Neurosurgery, and Psychiatry 78: 408–10.CrossRefGoogle Scholar
Zamel, R., Khan, R., Pollex, R. L., and Hegele, R. A. (2008). “Abetalipoproteinemia: two case reports and literature review,” Orphanet Journal of Rare Diseases 3: 19.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×